Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study

被引：0
|
作者：
Hedner, J.
Loft, H.
Hajak, G.
Lundahl, J.
Hedegaard, K.
Knoth, Sorensen H.
Torstenson, R.
机构：
[1] Sahlgrens Univ Hosp, Gothenburg, Sweden
[2] Univ Regensburg, D-8400 Regensburg, Germany
来源：
SLEEP | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
741
引用
收藏
页码：A252 / A253
页数：2
相关论文
共 50 条
  • [21] A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease
    Imbimbo, BP
    Troetel, WM
    Martelli, P
    Lucchelli, F
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (01) : 17 - 24
  • [22] ERGOLOID MESYLATES (HYDERGINE) IN THE TREATMENT OF MENTAL DETERIORATION IN THE ELDERLY - A 6-MONTH DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    ROUY, JM
    DOUILLON, AM
    COMPAN, B
    WOLMARK, Y
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (06) : 380 - 389
  • [23] Zolpidem "as needed" for the treatment of primary insomnia: A double-blind, placebo-controlled study
    Walsh, JK
    [J]. SLEEP MEDICINE REVIEWS, 2002, 6 : S7 - S11
  • [24] Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study
    Montes, LGA
    Uribe, MPO
    Sotres, JC
    Martin, GH
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (03): : 191 - 196
  • [25] Effect of tiagabine on sleep in elderly subjects with primary insomnia: A randomized, double-blind, placebo-controlled study
    Roth, Thomas
    Wright, Kenneth P., Jr.
    Walsh, James
    [J]. SLEEP, 2006, 29 (03) : 335 - 341
  • [26] Doxepin in the treatment of primary insomnia:: A placebo-controlled, double-blind, polysomnographic study
    Hajak, G
    Rodenbeck, A
    Voderholzer, U
    Riemann, D
    Cohrs, S
    Hohagen, F
    Berger, M
    Rüther, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (06) : 453 - 463
  • [27] Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
    Scharf, Martin
    Rogowski, Roberta
    Hull, Steven
    Cohn, Martin
    Mayleben, David
    Feldman, Neil
    Ereshefsky, Larry
    Lankford, Alan
    Roth, Thomas
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) : 1557 - 1564
  • [28] Effects of metrifonate on cognitive decline in Alzheimer disease: A double-blind, placebo-controlled, 6-month study
    Becker, RE
    Colliver, JA
    Markwell, SJ
    Moriearty, PL
    Unni, LK
    Vicari, S
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (01): : 54 - 57
  • [29] DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND TOLERABILITY OF SUPROFEN SUPPOSITORIES IN PATIENTS WITH OSTEOARTHRITIC PAIN
    VIARA, M
    MENICANTI, V
    NEBIOLO, M
    MICHOS, N
    SARCHI, C
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (07): : 1113 - 1115
  • [30] Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomnia
    Roth, Thomas
    Soubrane, Christina
    Titeux, Laurence
    Walsh, James K.
    [J]. SLEEP MEDICINE, 2006, 7 (05) : 397 - 406
12345